The genomic and transcriptional landscape of primary central nervous system lymphoma
Abstract Primary lymphomas of the central nervous system (PCNSL) are mainly diffuse large B-cell lymphomas (DLBCLs) confined to the central nervous system (CNS). Despite extensive research, the molecular alterations leading to PCNSL have not been fully elucidated. In order to provide a comprehensive description of the genomic and transcriptional landscape of PCNSL, we here performed whole-genome and transcriptome sequencing and integrative analysis of 51 lymphomas presenting in the CNS, including 42 EBV-negative PCNSL, 6 secondary CNS lymphomas (SCNSL) and 3 EBV+ CNSL and matched controls. The results were compared to an independent validation cohort of 31 FFPE CNSL specimens (PCNSL, n = 19; SCNSL, n = 9; EBV+ CNSL, n = 3) as well as 39 FL and 36 systemic DLBCL cases outside the CNS. Somatic genomic alterations in PCNSL mainly affect the JAK-STAT, NFkB, and B-cell receptor signaling pathways, with hallmark recurrent mutations including MYD88 L265P (67%) and CD79B (63%), CDKN2A deletions (83%) and also non-coding RNA genes such as MALAT1 (70%), NEAT (60%), and MIR142 (80%). Kataegis events, which affected 15 of 50 identified driver genes and 21 of the top 50 mutated ncRNAs, played a decisive role in shaping the mutational repertoire of PCNSL. Compared to systemic DLBCL, PCNSLs exhibited significantly more focal deletions in 6p21 targeting the HLA-D locus that encodes for MHC class II molecules as a potential mechanism of immune evasion. Mutational signatures correlating with DNA replication and mitosis (SBS1, ID1 and ID2) were significantly enriched in PCNSL (SBS1: p = 0.0027, ID1/ID2: p < 1×10−4). Furthermore, TERT gene expression was significantly higher in PCNSL compared to ABC-DLBCL (p = 0.027). Although PCNSL share many genetic alterations with systemic ABC-DLBCL in the same signaling pathways, transcriptome analysis clearly distinguished both into distinct molecular subtypes. EBV+ CNSL cases may be distinguished by lack of recurrent mutational hotspots apart from IG and HLA-DRB loci..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
bioRxiv.org - (2021) vom: 09. Aug. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| doi: |
10.1101/2021.07.30.21261280 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI032336500 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI032336500 | ||
| 003 | DE-627 | ||
| 005 | 20230429090734.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210806s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2021.07.30.21261280 |2 doi | |
| 035 | |a (DE-627)XBI032336500 | ||
| 035 | |a (biorXiv)10.1101/2021.07.30.21261280 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Radke, Josefine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a The genomic and transcriptional landscape of primary central nervous system lymphoma |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Primary lymphomas of the central nervous system (PCNSL) are mainly diffuse large B-cell lymphomas (DLBCLs) confined to the central nervous system (CNS). Despite extensive research, the molecular alterations leading to PCNSL have not been fully elucidated. In order to provide a comprehensive description of the genomic and transcriptional landscape of PCNSL, we here performed whole-genome and transcriptome sequencing and integrative analysis of 51 lymphomas presenting in the CNS, including 42 EBV-negative PCNSL, 6 secondary CNS lymphomas (SCNSL) and 3 EBV+ CNSL and matched controls. The results were compared to an independent validation cohort of 31 FFPE CNSL specimens (PCNSL, n = 19; SCNSL, n = 9; EBV+ CNSL, n = 3) as well as 39 FL and 36 systemic DLBCL cases outside the CNS. Somatic genomic alterations in PCNSL mainly affect the JAK-STAT, NFkB, and B-cell receptor signaling pathways, with hallmark recurrent mutations including MYD88 L265P (67%) and CD79B (63%), CDKN2A deletions (83%) and also non-coding RNA genes such as MALAT1 (70%), NEAT (60%), and MIR142 (80%). Kataegis events, which affected 15 of 50 identified driver genes and 21 of the top 50 mutated ncRNAs, played a decisive role in shaping the mutational repertoire of PCNSL. Compared to systemic DLBCL, PCNSLs exhibited significantly more focal deletions in 6p21 targeting the HLA-D locus that encodes for MHC class II molecules as a potential mechanism of immune evasion. Mutational signatures correlating with DNA replication and mitosis (SBS1, ID1 and ID2) were significantly enriched in PCNSL (SBS1: p = 0.0027, ID1/ID2: p < 1×10−4). Furthermore, TERT gene expression was significantly higher in PCNSL compared to ABC-DLBCL (p = 0.027). Although PCNSL share many genetic alterations with systemic ABC-DLBCL in the same signaling pathways, transcriptome analysis clearly distinguished both into distinct molecular subtypes. EBV+ CNSL cases may be distinguished by lack of recurrent mutational hotspots apart from IG and HLA-DRB loci. | ||
| 700 | 1 | |a Ishaque, Naveed |e verfasserin |4 aut | |
| 700 | 1 | |a Koll, Randi |e verfasserin |4 aut | |
| 700 | 1 | |a Gu, Zuguang |e verfasserin |4 aut | |
| 700 | 1 | |a Schumann, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Sieverling, Lina |e verfasserin |4 aut | |
| 700 | 1 | |a Uhrig, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Hübschmann, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Toprak, Umut H. |e verfasserin |4 aut | |
| 700 | 1 | |a López, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Hostench, Xavier Pastor |e verfasserin |4 aut | |
| 700 | 1 | |a Borgoni, Simone |e verfasserin |4 aut | |
| 700 | 1 | |a Juraeva, Dilafruz |e verfasserin |4 aut | |
| 700 | 1 | |a Pritsch, Fabienne |e verfasserin |4 aut | |
| 700 | 1 | |a Paramasivam, Nagarajan |e verfasserin |4 aut | |
| 700 | 1 | |a Balasubramanian, Gnana Prakash |e verfasserin |4 aut | |
| 700 | 1 | |a Schlesner, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Sahay, Shashwat |e verfasserin |4 aut | |
| 700 | 1 | |a Pehl, Debora |e verfasserin |4 aut | |
| 700 | 1 | |a Radbruch, Helena |e verfasserin |4 aut | |
| 700 | 1 | |a Osterloh, Anja |e verfasserin |4 aut | |
| 700 | 1 | |a Korfel, Agnieszka |e verfasserin |4 aut | |
| 700 | 1 | |a Misch, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Onken, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Faust, Katharina |e verfasserin |4 aut | |
| 700 | 1 | |a Vajkoczy, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Moskopp, Dag |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yawen |e verfasserin |4 aut | |
| 700 | 1 | |a Jödicke, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Trümper, Lorenz |e verfasserin |4 aut | |
| 700 | 1 | |a Anagnostopoulos, Ioannis |e verfasserin |4 aut | |
| 700 | 1 | |a Lenze, Dido |e verfasserin |4 aut | |
| 700 | 1 | |a Hummel, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Schmitt, Clemens A. |e verfasserin |4 aut | |
| 700 | 1 | |a Wiestler, Otmar D. |e verfasserin |4 aut | |
| 700 | 1 | |a Wolf, Stephan |e verfasserin |4 aut | |
| 700 | 1 | |a Unterberg, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Eils, Roland |e verfasserin |4 aut | |
| 700 | 1 | |a Herold-Mende, Christel |e verfasserin |4 aut | |
| 700 | 1 | |a Brors, Benedikt |e verfasserin |4 aut | |
| 700 | 1 | |a Siebert, Reiner |e verfasserin |4 aut | |
| 700 | 1 | |a Wiemann, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Heppner, Frank L. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2021) vom: 09. Aug. |
| 773 | 1 | 8 | |g year:2021 |g day:09 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.07.30.21261280 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 09 |c 08 | ||
| 953 | |2 045F |a 570 | ||